Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Podda

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
Vaccine|March 21, 2001
The adjuvanted influenza vaccines with novel adjuvants: experience with the MF59-adjuvanted vaccineA Podda
Vaccine|October 6, 2001
What are the limits of adjuvanticity?G Del Giudice, A Podda, R Rappuoli
Clinical Pharmacology and Therapeutics|November 1, 2007
MF59 is a safe and potent vaccine adjuvant for flu vaccines in humans: what did we learn during its development?D T O'Hagan, A Wack, A Podda
Advances in Experimental Medicine and Biology|January 1, 1991
Genetic approaches to a vaccine for pertussisL Nencioni, M Pizza, G Volpini, et al.
Developments in Biological Standardization|December 17, 1998
Measuring protection; a case study of pertussis vaccines--Swedish Trial II: secondary non-randomized comparisons between two schedules of infant vaccinationP Olin, H O Hallander, L Gustafsson, et al.
Progress in Clinical and Biological Research|January 1, 1989
Interaction between deletion delta-thalassemia and beta zero-thalassemia (codon 39 nonsense mutation) in a Sardinian familyR Galanello, A Podda, M A Melis, et al.
The European Respiratory Journal|March 1, 1991
Protective effect and duration of action of formoterol aerosol on exercise-induced asthmaA Patessio, A Podda, M Carone, et al.
Trends in Biotechnology|July 1, 1991
Towards third-generation whooping cough vaccinesR Rappuoli, M Pizza, A Podda, et al.
Vaccine|September 21, 2010
Associations of the correlates of protection and implication on the statistical power for demonstrating non-inferiority: application of a re-sampling method on a large phase III influenza vaccine clinical trialR Bugarini, D Casula, N Groth, et al.
The Neuroradiology Journal|July 18, 2013
Nosocomial Herpes Encephalitis: rare but treatable with early MR diagnosisP Doshi, M J Donovan Post, G Saigal, et al.
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Vaccine|March 21, 2001
The adjuvanted influenza vaccines with novel adjuvants: experience with the MF59-adjuvanted vaccineA Podda
Vaccine|October 6, 2001
What are the limits of adjuvanticity?G Del Giudice, A Podda, R Rappuoli
Clinical Pharmacology and Therapeutics|November 1, 2007
MF59 is a safe and potent vaccine adjuvant for flu vaccines in humans: what did we learn during its development?D T O'Hagan, A Wack, A Podda
Advances in Experimental Medicine and Biology|January 1, 1991
Genetic approaches to a vaccine for pertussisL Nencioni, M Pizza, G Volpini, et al.
Developments in Biological Standardization|December 17, 1998
Measuring protection; a case study of pertussis vaccines--Swedish Trial II: secondary non-randomized comparisons between two schedules of infant vaccinationP Olin, H O Hallander, L Gustafsson, et al.
Progress in Clinical and Biological Research|January 1, 1989
Interaction between deletion delta-thalassemia and beta zero-thalassemia (codon 39 nonsense mutation) in a Sardinian familyR Galanello, A Podda, M A Melis, et al.
The European Respiratory Journal|March 1, 1991
Protective effect and duration of action of formoterol aerosol on exercise-induced asthmaA Patessio, A Podda, M Carone, et al.
Trends in Biotechnology|July 1, 1991
Towards third-generation whooping cough vaccinesR Rappuoli, M Pizza, A Podda, et al.
Vaccine|September 21, 2010
Associations of the correlates of protection and implication on the statistical power for demonstrating non-inferiority: application of a re-sampling method on a large phase III influenza vaccine clinical trialR Bugarini, D Casula, N Groth, et al.
The Neuroradiology Journal|July 18, 2013
Nosocomial Herpes Encephalitis: rare but treatable with early MR diagnosisP Doshi, M J Donovan Post, G Saigal, et al.
Pageof 6